Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
Open accessThe DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Abstract
Background Genexol-PM is a novel Cremophor EL (CrEL)-free polymeric micelle formulation of paclitaxel (Taxol). This multicenter phase II study was designed to evaluate the efficacy and safety of the combination of Genexol-PM and cisplatin for the treatment of advanced non-small-cell lung cancer (NSCLC).Patients and methods Patients with advanced NSCLC received Genexol-PM 230 mg/m(2) and cisplatin 60 mg/m(2) on day 1 of a 3-week cycle as first-line therapy. Intrapatient dose escalation of Genexol-PM to 300 mg/m(2) was carried out from the second cycle if the prespecified toxic effects were not observed after the first cycle.Results Sixty-nine patients were enrolled in this study. Overall response rate was 37.7%. The median time to progression was 5.8 months and the median survival period was 21.7 months. The major non-hematologic toxic effects included grade 3 peripheral sensory neuropathy (13.0%) and grade 3/4 arthralgia (7.3%). Four patients (5.8%) experienced grade 3/4 hypersensitivity reactions. The major hematological toxic effects were grade 3/4 neutropenia (29.0% and 17.4%, respectively).Conclusion Genexol-PM plus cisplatin combination chemotherapy showed significant antitumor activity. The use of CrEL-free, polymeric micelle formulation of paclitaxel allowed administration of higher doses of paclitaxel compared with the CrEL-based formulation without significant increased toxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although Genexol® PM has shown some hypersensitivity reaction in the clinic, probably due to the PEG, this is not nearly as much of a concern as for Taxol® which contains Cremophor EL [301].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [301]
In the citing paper
“The overall response rate was 37.7% and the median survival period was 21.7 months, which indicated significant improvements compared to previous clinical trials conducted with Taxol® 175–200 mg/m2 and cisplatin 75–80 mg/m2 [301].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [301]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
Chiller, J. O. H. S., Arrington, D. A. H., Elani, C. H. P. B., Anger, C., Andler, A. L. S., Rook, J. A. K., Hu, J., & Ohnson, D. A. H. J. (2002) · Cited by 3,730
Rowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Self-citationIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy
Kim, S. C., Kim, D. W., Shim, Y. H., Bang, J. S., Oh, H. S., Kim, S. W., & Seo, M. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00275-9 · Cited by 734
Self-citation
Cited by
Items 301–391 of 391
Polymeric Micelles for Multiple-Drug Delivery
Kwon, G. S. (2012) · Nanostructure science and technology · doi:10.1007/978-1-4614-2305-8_7 · Cited by 3
Role of new pharmaceutical technologies in enhancing the selectivity of antitumor drugs
Оборотова, Н. А., & Санарова, Е. В. (2013) · Russian Journal of General Chemistry · doi:10.1134/s1070363213120529 · Cited by 3
Choudhary, V., Raut, N. V., Panchal, G., Khalse, M., & Patel, K. (2026) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0046-1816044 · Cited by 2
Modernization of traditional Chinese medicine in cancer therapy: “3 D”innovative Chinese medicine
Liu, H. L. Y., Ge, Y., & Dong, Z. (2026) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(26)61090-4 · Cited by 3
Nanoprobes for advanced nanotheranostic applications
Saleemi, M. A., & Wong, E. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85785-7.00006-1 · Cited by 2
Multifunctional Polymeric Micelles for Drug Delivery and Therapeutics
Sawdon, A. J., & Peng, C. (2013) · Wiley eBooks · doi:10.1002/9781118636299.ch15 · Cited by 2
A Case of Delayed Severe Hypersensitivity Reaction during Genexol-PM® Infusion
Kim, H. K., Kim, S. W., Kang, H. W., Kwon, K. J., Park, H. S., Ryu, Y. J., Lee, J. H., Chun, E. M., Cho, Y.-J., & Chang, J. H. (2010) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2010.68.5.294 · Cited by 2
Self-citationDrug Delivery Vehicles from Stimuli‐Responsive Block Copolymers
Kulkarni, P., & Mallik, S. (2018) · Wiley eBooks · doi:10.1002/9781119156253.ch7 · Cited by 2
Advanced drug delivery systems in lung cancer
Philip, A. K., & Samuel, B. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00024-9 · Cited by 2
Review Deciphering the Potential of Nanotherapeutics in Lung Cancer Management
Chauhan, P. K., Pandey, P., Ramniwas, S., & Khan, F. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096302203240308104740 · Cited by 2
IG-001 - A Non-Biologic Nanoparticle Paclitaxel for the Treatment of Solid Tumors
Motamed, K. (2014) · Journal of Nanomaterials & Molecular Nanotechnology · doi:10.4172/2324-8777.1000136 · Cited by 2
Design, Development and Evaluation of Dual Drug Nanomedicine for Non-Small Cell Lung Cancer
Hatami, E. (2020) · doi:10.21007/etd.cghs.2019.0493 · Cited by 2
Π-π Stacked Polymeric Micelles as Carriers of Anticancer Therapeutics for Hematological Malignancies
Varela-Moreira, A. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/145 · Cited by 2
Nagampalli, R. S. K., & Nadendla, E. K. (2024) · International Journal of Advanced Nano Computing and Analytics · doi:10.61797/ijanca.v3i2.397 · Cited by 2
Clinical Validations of Localized Cancer Nanomedicine
Chandpa, H. H., Naskar, S., Kumbhar, P. A., Singh, A., & Meena, J. (2025) · Springer eBooks · doi:10.1007/978-981-95-0938-6_7 · Cited by 1
Wei, M., Zeng, D., Zhao, X., Gao, F., & Ma, A. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c10453 · Cited by 1
Li, D., Wang, X., Zhao, J., Shi, M., Chen, B., & Su, G. (2025) · Alexandria Engineering Journal · doi:10.1016/j.aej.2025.12.002 · Cited by 1
Zheng, L., Chong, L.-C., & Zhai, X. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1778133 · Cited by 1
Park, C.-K., Kang, H.-W., Kim, T.-O., Ki, H.-S., Kim, E. Y., Ban, H., Yoon, B. K., Oh, I., Choi, Y.-D., Kwon, Y. S., et al. (2010) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2010.69.2.115 · Cited by 1
Nanomedicine Magic Bullet for Human Cancer
Patnaik, S. (2014) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-4666-6363-3.ch009 · Cited by 1
Nanostructrue and Function of PEGylated Phospholipid Micelles Encapsulation Drugs
Wei, X., & LIANG, W. (2013) · ACTA AGRONOMICA SINICA · doi:10.3724/sp.j.1206.2013.00290 · Cited by 1
Overview of Polylactide-co-Glycolide Drug Delivery Systems
Sah, H. (2016) · Pan Stanford eBooks · doi:10.1201/b20045-7 · Cited by 1
Polymeric Nanosystems for Integrated Image-Guided Cancer Therapy
Singh, A., Iyer, A. K., & Amiji, M. M. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0006 · Cited by 1
Engineered Nanoparticle for Targeted and Controlled Drug Delivery
Zhou, Z. (2017) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Satyal, U., Sharma, V. D., Shif, J., & Ilies, M. A. (2017) · ACS symposium series · doi:10.1021/bk-2017-1271.ch009 · Cited by 1
Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
Кедрова, А. Г., Krasilnikov, S. E., Астахов, Д. А., & Kosyy, V. V. (2019) · Tumors of female reproductive system · doi:10.17650/1994-4098-2019-15-3-37-43 · Cited by 1
Emerging strategies in nanotheranostics: A paradigm shift
Sahu, J. R., Sahoo, T., Priyadarshini, A., Senapati, D. K., Bisoi, D., Parida, S., Ghosh, G., & Sahu, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85725-3.00013-1 · Cited by 1
Photo-triggered theranostics nanomaterials: Development and challenges in cancer treatment
Raut, N., Zambre, D., Umekar, M. J., & Dhoble, S. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89839-3.00022-1 · Cited by 1
Nanoencapsulation of tyrosine kinase inhibitors for oncological therapeutics
Nguyen, H. L., Gupta, R. K., & Nguyen, T. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91229-7.00014-3 · Cited by 1
Gaucher, G. (2009) · doi:10.71781/4932 · Cited by 1
Targeted delivery of anti-cancer drugs by MS2 virus-like particles
Yan, R. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Nanofabrication and Spectroscopy of Magnetic Nanostructures Using a Focused Ion Beam
Hadjikhani, A. (2016) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc000785 · Cited by 1
Ang, J. (2016) · eScholarship (California Digital Library) · Cited by 1
Development of novel nanoparticle-based therapeutics for treatment of lung cancer
Bölükbas, D. A. (2017) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.20933 · Cited by 1
Synthesis and self-assembly of biocompatible amphiphilic block copolymers
Bertani, D. (2018) · BOA (University of Milano-Bicocca) · Cited by 1
Poly(2-oxazoline)s as new drug delivery systems
He, Z. (2015) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/er9f-gq81 · Cited by 1
Radaha, E. L. (2021) · K-State Research Exchange (Kansas State University) · Cited by 1
Formulation nanométrique de la molécule anti-pathogènes intracellulaires Retro-2.1
Vinck, R. (2019) · theses.fr (ABES) · doi:10.70675/5547f887z0f37z4582z8cefz41e860d237b9 · Cited by 1
N-vinylpyrrolidone-vinyl acetate block copolymers as drug delivery vehicles
Bailly, N. (2012) · SUNScholar (Stellenbosch University) · Cited by 1
Smart-Drug Delivery and Target-Specific Therapy
Shaposhnik, Z., & Tamanoi, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-444-53632-7.01022-4
TARGETED THERAPY FOR LIVER FIBROSIS AND CANCER
Zhang, Y. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Self-assembled polymeric micelles as powders for pulmonary administration of insulin
Andrade, F. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/ccbg-k109
Janat-Amsbury, M. M., & Bae, Y. H. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9135-4_35
Towards a targeted non-invasive diagnosis and treatment of endometrial pathologies
Zisimopoulou, A. (2015) · ePrints Soton (University of Southampton)
Polymeric micelles as versatile carriers for drugs and nucleic acids
Elsabahy, M. (2009) · doi:10.71781/4884
TARGETED DUAL FUNCTIONAL NANOPARTICLES FOR THE TREATMENT OF CANCER AND LIVER FIBROSIS
Ghazwani, M. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Smet, L. D. (2013) · Ghent University Academic Bibliography (Ghent University)
Core-Shell Nanoparticles for Biomedical Applications
Elsabahy, M., & Wooley, K. L. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0013
Nanopartículas poliméricas autoensambladas y bioactivas para el tratamiento del cáncer
Palao‐Suay, R. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Hoang, B. (2014) · TSpace (University of Toronto)
Design and Synthesis of Self-Assembled Polymeric Nanoparticles for Cancer Drug Delivery
Logie, J. (2017) · TSpace (University of Toronto)
Development of polymer and lipid based nano-delivery systems for targeted cancer chemotherapy
Shahin, M. (2012) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3vt1gz32
Reshaping the Immunosuppressive Tumor Microenvironment: The Fusion Protein Strategy
Wei, Y. (2016) · Cell & Cellular Life Sciences Journal · doi:10.23880/cclsj-16000102
Development of multi-functionalized polymeric carriers for delivery of anticancer drug combinations
Phuoc, D. H. H. (2013) · National University of Singapore
Amphiphilic Polymers: Drug Delivery
Rafael, D. F. D. S., Videira, M., Oliva, M., Ferreira, D., Sarmento, B. F. C. C., & Andrade, F. (2015) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120049256
Kumar, C. S. S. (2016) · Taylor & Francis eBooks · doi:10.1081/e-ebpp-120049993
Mulet-Margalef, N., Miquel, J. M., & Rodon, J. A. (2014) · doi:10.4155/ebo.13.482
Lung cancer: Improving efficacy and reducing side effects
Jain, S., Raza, K., Agrawal, A. K., & Vaidya, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817846-1.00017-5
Implementation of Nanoparticles in Cancer Therapy
Bayır, E., Bilgi, E., & Şendemir, A. (2016) · IGI Global eBooks · doi:10.4018/978-1-5225-1762-7.ch047
Regulatory pathways and prospects for polymeric micelles
Jasim, A. A., Ashi, L., Mahmud, A. A., Pandey, M., Amin, M. C. I. M., & Greish, K. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00010-0
Jiangang Chen1, M. W. (2024) · International Journal of Frontiers in Medicine · doi:10.25236/ijfm.2024.061001
Development of Nanotheronostics
Shaikh, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-7292-6_21
Nanodrugs: Recent Development and Therapeutic Application
Malhotra, R., & Aathi, M. (2025) · Information systems engineering and management · doi:10.1007/978-3-031-77296-2_5
Role of Medicinal-Plant-Derived Nanoparticles Against Cancers
Kumar, R., Harilal, S., Kumar, B. T. N., Singh, A. K., Rajeshkumar, R., & Appukuttan, S. (2025) · Springer eBooks · doi:10.1007/978-3-032-03604-9_12
Development of Paclitaxel Injection Concentrate for Nanodispersion
Khopade, A. J., Shah, M. D., & Borole, B. S. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03269-3
"O papel da nanomedicina no tratamento do cancro do pulmão"
Lopes, I. M. D. A. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
In vivo response to antioxidant nanomedicines using a zebrafish model
Hold, I. (2016) · Unipub UB Graz (Universität Graz)
Drug and gene delivery systems based on polymers derived from bile acids
Cunningham, A. J. (2021) · doi:10.71781/11401
Alternative au polyéthylène glycol dans la préparation de vecteurs pharmaceutiques
Roussel, S. (2021) · Corpus Université Laval (Université Laval)
Nanoparticles In Cancer Therapy: Advances, Challenges and Future Directions
Sawant, P., Gharat, G., & Harad, V. (2025) · International Journal of Novel Research and Development · doi:10.56975/ijnrd.v10i12.311481
Exploration of treatment after multiline chemotherapy in recurrent head and neck cancer: Case report
Wang, Y., Huangfu, C., Jiang, J., & Dai, W. (2026) · Medicine · doi:10.1097/md.0000000000047059
Current perspectives of nanovaccines and nanomedicines in cancer treatment
Butt, A., Noor, A., & Din, F. U. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44579-8.00010-2
Nanotechnology and drug delivery: Fundamentals and applications
Purohit, A., Nema, P., Kumar, A., Kumar, N. D., Soni, V., & Kashaw, S. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44119-6.00017-3
Park, J. J., Kuo, G., Khandekar, A., Shin, S., Wang, L., Taneja, T., & Mao, X. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00012-x
Self-citationBiological response modifiers in drug delivery
Girhepunje, N., Dumore, N. G., qizi, A. Z. F., Dumore, M. N., Charde, M., Shende, S., Barai, M., Done, R., & Vinchurkar, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40620-1.00012-1
Kumar, R. R., & Enoch, I. V. M. V. (2026) · Lung Cancer · doi:10.1016/j.lungcan.2026.109518
Micelles in cancer nanomedicine: targeted delivery, imaging, and therapy
Rashnoodi, A., Seraj, Z., Zamani, N., & Najafabad, B. K. (2026) · Academia Drug Development and Pharmacotherapy · doi:10.20935/acaddrug8458
مروری بر نانوذرات و کاربرد آنها در بیماریهای ریوی
عسکری, م., کربلایی, ع., & بهمنش, م. (2021) · Nafas Journal
Fundamental studies of poly(ethylene glycol-b-caprolactone) block copolymer self-assembly in water
Faisal, K. S. (2019) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Nanoparticles-Based Drug Delivery In Cancer Therapy: Current Progress And Challenges
padhi, N. R. K. P. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s10.493
(2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.76s.165
Formulation and Characterization of Paclitaxel-Loaded Nanoparticles For Targeted Cancer Therapy
Lall, D., Sahu, K., Sahu, D. C., Bisen, A., & Arjariya, B. K. (2026) · Adolescencia e Saude · doi:10.67440/ahj.vi.2805
Santos, P. M. M. D. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Drug delivery systems: current applications and future directions
Noh, K., Jung, E., Kim, J., Kim, E., Kim, S., & Yoo, W. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-03086-5
Self-citation
Metadata
- Authors
- Kim, D.-W., Kim, S.-Y., Kim, H.-K., Kim, S.-W., Shin, S. W., Kim, J. S., Park, K., Lee, M. Y., & Heo, D. S.
- Affiliations
- Seoul National University (KR)
- Asan Medical Center (KR)
- The Catholic University of Korea St. Vincent's Hospital (KR)
- Korea University Anam Hospital (KR)
- Samsung Medical Center (KR)
- Samyang Holdings (South Korea) (KR)
- Corresponding author
- Heo, D.S.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2007-12
- Volume
- 18
- Issue
- 12
- Pages
- 2009-2014
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2155680971
- Cited by
- 356
- References
- 27
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 19 · 2023: 13 · 2022: 24 · 2021: 12 · 2020: 22 · 2019: 15 · 2018: 19 · 2017: 18 · 2016: 30 · 2015: 24 · 2014: 31 · 2013: 28 · 2012: 17
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4385 d)
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- paclitaxel, polymeric micelles, cisplatin, non-small cell lung cancer, combination chemotherapy, first-line therapy, dose escalation, peripheral sensory neuropathy, neutropenia, hypersensitivity, anticancer activity
- MeSH terms
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Cisplatin, Female, Humans, Lung Neoplasms, Male, Micelles, Middle Aged, Polymers, Treatment Outcome, Paclitaxel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.